Your Health, We Care
Release date: 2026-01-05 14:26:49 Recommended: 13
It is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer whose tumors have been confirmed to harbor EGFR exon 19 deletions or exon 21 (L858R) substitution mu
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
